118 related articles for article (PubMed ID: 3654922)
21. Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate.
Pak CY; Sakhaee K; Parcel C; Poindexter J; Adams B; Bahar A; Beckley R
J Bone Miner Res; 1990 Aug; 5(8):857-62. PubMed ID: 2239370
[TBL] [Abstract][Full Text] [Related]
22. Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys.
Sakhaee K; Wabner CL; Zerwekh JE; Copley JB; Pak L; Poindexter JR; Pak CY
Bone Miner; 1993 Jan; 20(1):87-97. PubMed ID: 8453325
[TBL] [Abstract][Full Text] [Related]
23. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
Nestel AW; Meyers AM; Paiker J; Rollin HB
Nephron; 1994; 68(2):197-201. PubMed ID: 7830856
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal citrate absorption in nephrolithiasis.
Fegan J; Khan R; Poindexter J; Pak CY
J Urol; 1992 May; 147(5):1212-4. PubMed ID: 1569651
[TBL] [Abstract][Full Text] [Related]
25. The lack of influence of long-term potassium citrate and calcium citrate treatment in total body aluminum burden in patients with functioning kidneys.
Sakhaee K; Ruml L; Padalino P; Haynes S; Pak CY
J Am Coll Nutr; 1996 Feb; 15(1):102-6. PubMed ID: 8632109
[TBL] [Abstract][Full Text] [Related]
26. [Influence of tannic acid on physical and chemical properties of alpha-tricalcium phosphate-citric acid-tannic acid complex].
Sugihara F; Ishii T; Takano T; Hata S; Oonishi H
Shika Zairyo Kikai; 1989 Mar; 8(2):267-74. PubMed ID: 2603094
[TBL] [Abstract][Full Text] [Related]
27. [An enzymatic determination of serum citrate with citrate lyase].
Yasukawa S; Ebisuno S; Morimoto S; Uehara M; Ohkawa T
Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1748-53. PubMed ID: 1762264
[TBL] [Abstract][Full Text] [Related]
28. Creatinine, calcium, citrate and acid-base in spinal cord injured patients.
Burr RG; Chem C; Nuseibeh I
Paraplegia; 1993 Nov; 31(11):742-50. PubMed ID: 8295783
[TBL] [Abstract][Full Text] [Related]
29. The effect of oral bases on enteral aluminum absorption.
Walker JA; Sherman RA; Cody RP
Arch Intern Med; 1990 Oct; 150(10):2037-9. PubMed ID: 2171446
[TBL] [Abstract][Full Text] [Related]
30. Intestinal calcium absorption from different calcium preparations: influence of anion and solubility.
Hansen C; Werner E; Erbes HJ; Larrat V; Kaltwasser JP
Osteoporos Int; 1996; 6(5):386-93. PubMed ID: 8931033
[TBL] [Abstract][Full Text] [Related]
31. The influence of citrate, maltolate and fluoride on the gastrointestinal absorption of aluminum at a drinking water-relevant concentration: A 26Al and 14C study.
Zhou Y; Harris WR; Yokel RA
J Inorg Biochem; 2008 Apr; 102(4):798-808. PubMed ID: 18207247
[TBL] [Abstract][Full Text] [Related]
32. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate.
Hanzlik RP; Fowler SC; Fisher DH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1217-22. PubMed ID: 15734899
[TBL] [Abstract][Full Text] [Related]
33. Calcium absorption from a new calcium delivery system (CCM).
Smith KT; Heaney RP; Flora L; Hinders SM
Calcif Tissue Int; 1987 Dec; 41(6):351-2. PubMed ID: 3124946
[TBL] [Abstract][Full Text] [Related]
34. Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat.
Froment DH; Buddington B; Miller NL; Alfrey AC
J Lab Clin Med; 1989 Sep; 114(3):237-42. PubMed ID: 2769017
[TBL] [Abstract][Full Text] [Related]
35. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
36. Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents.
Miller JZ; Smith DL; Flora L; Slemenda C; Jiang XY; Johnston CC
Am J Clin Nutr; 1988 Nov; 48(5):1291-4. PubMed ID: 3189218
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
Heinrich HC
Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
[TBL] [Abstract][Full Text] [Related]
38. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
Harvey JA; Zobitz MM; Pak CY
J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
[TBL] [Abstract][Full Text] [Related]
39. Mononuclear titanium(IV)-citrate complexes from aqueous solutions: pH-specific synthesis and structural and spectroscopic studies in relevance to aqueous titanium(IV)-citrate speciation.
Kefalas ET; Panagiotidis P; Raptopoulou CP; Terzis A; Mavromoustakos T; Salifoglou A
Inorg Chem; 2005 Apr; 44(8):2596-605. PubMed ID: 15819544
[TBL] [Abstract][Full Text] [Related]
40. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
